Journal
BIOLOGICAL TRACE ELEMENT RESEARCH
Volume 155, Issue 2, Pages 287-294Publisher
HUMANA PRESS INC
DOI: 10.1007/s12011-013-9772-y
Keywords
Zinc oxide nanoparticles; MC3T3-E1 cells; Osteogenic differentiation
Funding
- National Research Foundation of Korea (NRF)
- Ministry of Education [2013004361]
Ask authors/readers for more resources
Zinc oxide nanoparticles (ZnO NPs) can be ingested directly when used in food, food packaging, drug delivery, and cosmetics. This study evaluated the cellular effects of ZnO NPs (50 and 100 nm diameter particle sizes) on the function of osteoblastic MC3T3-E1 cells. ZnO NPs showed cytotoxicity at concentrations of above 50 mu g/ml, and there was no significant effect of the size on the cytotoxicity of ZnO NPs. Within the testing concentrations of 0.01 similar to 1 mu g/ml, which did not cause a marked drop in cell viability, ZnO NPs (0.1 mu g/ml) caused a significant elevation of alkaline phosphatase activity, collagen synthesis, mineralization, and osteocalcin content in the cells (P < 0.05). Moreover, pretreatment with ZnO NPs (0.01 similar to 1 mu g/ml) significantly reduced antimycin A-induced cell damage by preventing mitochondrial membrane potential dissipation, complex IV inactivation, and ATP loss. Measurement of reactive oxygen species (ROS) indicated decrease in ROS level upon exposure to ZnO nanoparticles (0.01 mu g/ml). Hence, our study indicated that ZnO nanoparticles can have protective effects on osteoblasts at low concentrations where there are little or no observable cytotoxic effects.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available